Gene · 6595
Papers3,459
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,459
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor. | Blood | 2024 | 38437498 | PubTator, text mining | PubMed |
| [Gastrointestinal tumors with SWI/SNF complex deficiency: a clinicopathological analysis of 36 cases]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 38433055 | PubTator, text mining | PubMed |
| Retraction Note: Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin. | Oncogene | 2024 | 38396295 | PubTator, text mining | PubMed |
| Mutation of the SWI/SNF complex component Smarce1 decreases nucleosome stability in embryonic stem cells and impairs differentiation. | J Cell Sci | 2024 | 38357971 | PubTator, text mining | PubMed |
| SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma: Clinicopathologic and immunohistochemical study. | Hum Pathol | 2024 | 38307342 | PubTator, text mining | PubMed |
| BCL7A and BCL7B potentiate SWI/SNF-complex-mediated chromatin accessibility to regulate gene expression and vegetative phase transition in plants. | Nat Commun | 2024 | 38296999 | PubTator, text mining | PubMed |
| Utilizing a dual endogenous reporter system to identify functional regulators of aberrant stem cell and differentiation activity in colorectal cancer. | bioRxiv | 2024 | 38293113 | PubTator, text mining | PubMed |
| Diosgenin biosynthesis pathway and its regulation in Dioscorea cirrhosa L. | PeerJ | 2024 | 38282859 | PubTator, text mining | PubMed |
| The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant Cancers. | Cancers (Basel) | 2024 | 38275886 | PubTator, text mining | PubMed |
| SWI/SNF Complex in Vascular Smooth Muscle Cells and Its Implications in Cardiovascular Pathologies. | Cells | 2024 | 38247859 | PubTator, text mining | PubMed |
| An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms. | Exp Mol Pathol | 2024 | 38237798 | PubTator, text mining | PubMed |
| Response to PD-1 inhibitor in SMARCB1‑deficient undifferentiated rectal carcinoma with low TMB, proficient MMR and BRAF V600E mutation: a case report and literature review. | Diagn Pathol | 2024 | 38217014 | PubTator, text mining | PubMed |
| Radiosensitization of Osteosarcoma Cells Using the PARP Inhibitor Olaparib Combined with X-rays or Carbon Ions. | J Cancer | 2024 | 38213724 | PubTator, text mining | PubMed |
| Multi-omics integration identifies cell-state-specific repression by PBRM1-PIAS1 cooperation. | Cell Genom | 2024 | 38190100 | PubTator, text mining | PubMed |
| Genetic and brain similarity independently predict childhood anthropometrics and neighborhood socioeconomic conditions. | Dev Cogn Neurosci | 2024 | 38184855 | PubTator, text mining | PubMed |
| Establishment and characterization of a highly metastatic hepatocellular carcinoma cell line. | Bioengineered | 2024 | 38184822 | PubTator, text mining | PubMed |
| PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models. | J Med Chem | 2024 | 38180485 | PubTator, text mining | PubMed |
| [Clinicopathological features of gastric alpha-fetoprotein-producing adenocarcinoma with SWI/SNF complex deletion]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 38178747 | PubTator, text mining | PubMed |
| BAF45D-binding to HOX genes was differentially targeted in H9-derived spinal cord neural stem cells. | Sci Rep | 2024 | 38168763 | PubTator, text mining | PubMed |
| Colorectal Carcinoma With Sarcomatoid Components: Report of 15 Cases and Literature Review of an Exceedingly Rare Carcinoma Subtype. | Am J Surg Pathol | 2024 | 38155543 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6595/papers?page=12